Regression of castration-resistant prostate cancer by a novel compound QW07 targeting androgen receptor N-terminal domain
Sign Up to like & getrecommendations! Published in 2020 at "Cell Biology and Toxicology"
DOI: 10.1007/s10565-020-09511-x
Abstract: Androgen deprivation therapy (ADT) via surgical or chemical castration frequently fails to halt lethal castration-resistant prostate cancer (CRPC), which is induced by multiple mechanisms involving constitutive androgen receptor (AR) splice variants, AR mutation, and/or de… read more here.
Keywords: qw07; androgen; prostate cancer; compound ... See more keywords